A vs ILMN vs TECH Stock Comparison

Agilent Technologies, Illumina and Bio-Techne Prices as of Oct 26, 2026 Peers: Industry group
1 more company in this comparison (QGEN) Create a free account to keep reading and compare up to 10 companies.
A Agilent Technologies, Inc.
$175.96 +1.8% 1M +18.9% 1Y
Market cap
$49.61B
P/E
34.5x
Revenue (TTM)
$7.37B
Div. yield
0.59%
Life Sciences Tools Healthcare
8 wins
ILMN Illumina, Inc.
$271.04 +0.4% 1M +170.7% 1Y
Market cap
$40.93B
P/E
49.6x
Revenue (TTM)
$4.49B
Div. yield
–
Life Sciences Tools Healthcare
2 wins
TECH BIO-TECHNE Corp
$72.69 +0.1% 1M +10.3% 1Y
Market cap
$11.35B
P/E
62.3x
Revenue (TTM)
$1.22B
Div. yield
0.44%
Life Sciences Tools Healthcare
2 wins

Head to Head

12 decided of 12

Agilent Technologies leads on 8 of the 12 questions below (Agilent Technologies 8, Illumina 2, Bio-Techne 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAILMNTECHLeader
Larger companyMarket capitalisation $49.61B $40.93B $11.35B A
Cheaper on earningsLower P/E, profitable companies only 34.5x 49.6x 62.3x A
Cheaper on forward earningsLower price / next fiscal year consensus EPS 26.9x 54.2x 33.5x A
Faster revenue growthRevenue growth, trailing twelve months +8.6% +4.9% -0.4% A
More profitableNet margin, trailing twelve months 19.5% 18.4% 15.0% A
Better return on capitalReturn on invested capital 13.1% 15.1% 8.3% ILMN
Less leveragedLower net debt / EBITDA 1.1x 0.7x -0.2x TECH
Higher dividend yieldTrailing dividend yield 0.59% — 0.44% A
Better 1-year returnPrice return, last 12 months +18.9% +170.7% +10.3% ILMN
Better 5-year returnAnnualised price return, 5 years +2.5%/yr -7.5%/yr -10.6%/yr A
Less volatileAnnualised volatility, 1 year 32.4% 50.4% 43.6% A
Higher overall scoreMean of the five percentile scores vs peers 62/100 65/100 66/100 TECH

Percentile Scorecard

AILMNTECH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAILMNTECH
Valuation 58 #97 of 228 52 #111 of 228 58 #96 of 228
Growth 36 #141 of 221 44 #124 of 221 39 #136 of 221
Profitability 91 #20 of 208 97 #7 of 208 94 #14 of 208
Financial Health 55 #108 of 239 51 #118 of 239 86 #35 of 239
Shareholder Returns 71 #40 of 137 84 #23 of 137 52 #67 of 137
Overall 62 65 66
  • A ranked among 248 companies in Medical Devices and Diagnostics
  • ILMN ranked among 248 companies in Medical Devices and Diagnostics
  • TECH ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAILMNTECHSPY
1 month +1.8%+0.4%+0.1% -0.8%
3 months +27.6%+43.1%+1.5% +3.5%
6 months +52.2%+110.9%+31.9% +7.0%
Year to date +29.3%+106.6%+23.6% +12.2%
1 year +18.9%+170.7%+10.3% +13.0%
3 years +71.2%+155.1%+22.1% +86.3%
3 years, per year +19.6%+36.7%+6.9% +23.1%
5 years +13.3%-32.4%-43.0% +68.6%
5 years, per year +2.5%-7.5%-10.6% +11.0%
10 years +305.7%+99.1%+186.5% +258.0%
10 years, per year +15.0%+7.1%+11.1% +13.6%

Risk

MeasureAILMNTECHSPY
Volatility, 1Y 32.4%50.4%43.6% 12.7%
Downside volatility, 1Y 27.5%39.1%43.6% 12.7%
Beta vs S&P 500, 1Y 0.880.810.77 1.00
Return / volatility, 1Y 0.583.390.24 1.02
Max drawdown, 5Y -39.6%-82.9%-67.0% -25.4%
From 52-week high -1.0%-7.7%0.0% -1.8%
52-week high $177.72$293.69$72.69 $779.14
52-week low $110.24$95.03$43.30 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAILMNTECH
P/E now vs peer median 34.5xmedian 30.6x 49.6xmedian 30.6x 62.3xmedian 30.6x
P/S now vs peer median 6.7xmedian 3.0x 9.1xmedian 3.0x 9.3xmedian 3.0x
EV/EBITDA now vs peer median 27.1xmedian 17.5x 36.2xmedian 17.5x 32.3xmedian 17.5x
P/FCF now vs peer median 39.2xmedian 23.3x 44.0xmedian 23.3x 43.1xmedian 23.3x
P/B now vs peer median 6.7xmedian 2.4x 14.4xmedian 2.4x 5.4xmedian 2.4x
PEG now vs peer median 3.51median 0.87 1.65median 0.87 -4.77median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAILMNTECH
Revenue $7.37B $4.49B $1.22B
Gross profit $3.97B $2.98B $799.07M
Operating income $1.64B $882.00M $251.89M
Net income $1.44B $825.00M $181.86M
Free cash flow $1.27B $931.00M $263.22M
R&D $485.00M $960.00M $94.77M
EPS (diluted) $5.09 $5.39 $1.16
Cash & equivalents $1.76B $1.04B $264.71M
Total debt $3.95B $1.99B $200.00M
Shares (diluted) 283.00M 153.00M 157.01M
Enterprise value $42.50B $35.69B $10.55B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAILMNTECH
P/E 34.5x 49.6x 62.3x
P/FCF 39.2x 44.0x 43.1x
P/Operating cash flow 30.8x 37.4x 38.8x
P/S 6.7x 9.1x 9.3x
P/B 6.7x 14.4x 5.4x
P/Tangible book 7.7x 16.9x 6.3x
EV/EBITDA 27.1x 36.2x 32.3x
EV/EBIT 31.6x 47.3x 44.8x
EV/Revenue 7.0x 9.3x 9.3x
EV/FCF 40.9x 44.8x 42.9x
EV/Operating cash flow 32.2x 38.1x 38.6x
PEG (3Y EPS CAGR) 3.51 1.65 -4.77

Growth

14 metrics
MetricAILMNTECH
Revenue growth (1Y) 8.6% 4.9% -0.4%
Revenue CAGR (3Y) 1.8% -1.0% 2.2%
Gross profit growth (1Y) 11.2% 4.6% 1.1%
Gross profit CAGR (3Y) 3.7% 2.9% 1.3%
Operating income growth (1Y) 13.5% -31.8% 146.3%
Operating income CAGR (3Y) 5.1% 28.3% -5.5%
Net income growth (1Y) 18.0% -34.4% 147.8%
Net income CAGR (3Y) 8.3% 30.0% -14.0%
EPS growth (1Y) 18.9% -32.7% 152.0%
EPS CAGR (3Y) 9.8% 30.1% -13.1%
Operating cash flow growth (1Y) 7.6% -5.1% 1.6%
Operating cash flow CAGR (3Y) -1.9% 38.1% 4.7%
Free cash flow growth (1Y) 16.5% -9.7% 2.6%
Free cash flow CAGR (3Y) -3.7% 105.0% 6.8%

Profitability

14 metrics
MetricAILMNTECH
Gross margin 53.8% 66.4% 65.8%
EBITDA margin 25.9% 25.7% 28.7%
Operating margin 22.2% 19.6% 20.7%
Pretax margin 22.5% 22.6% 19.8%
Net margin 19.5% 18.4% 15.0%
FCF margin 17.2% 20.7% 21.7%
Operating cash flow margin 21.8% 24.4% 24.0%
Return on equity 19.9% 29.9% 8.7%
Return on assets 10.7% 12.5% 7.1%
Return on invested capital 13.1% 15.1% 8.3%
Return on capital employed 14.6% 17.5% 10.5%
Asset turnover 0.5x 0.7x 0.5x
Cash conversion (OCF / net income) 1.1x 1.3x 1.6x
Stock comp / revenue 1.8% 5.9% 0.5%

Financial Health

11 metrics
MetricAILMNTECH
Debt / assets 28.3% 29.9% 7.7%
Debt / equity 0.5x 0.7x 0.1x
Net debt / EBITDA 1.1x 0.7x -0.2x
Debt / FCF 3.1x 2.1x 0.8x
Liabilities / assets 47.3% 57.3% 18.5%
Equity / assets 52.7% 42.7% 81.5%
Interest coverage 15.5x 8.9x 26.2x
Current ratio 2.1x 1.8x 4.5x
Quick ratio 1.4x 1.2x 2.9x
Cash ratio 0.8x 0.7x 1.6x
Altman Z-score 5.82 7.77 15.91

Shareholder Returns

7 metrics
MetricAILMNTECH
Dividend yield 0.6% – 0.4%
Net buyback yield 0.6% 1.2% -0.3%
Shareholder yield 1.2% 1.2% 0.1%
Payout ratio (earnings) 19.9% – 27.4%
Payout ratio (FCF) 22.6% – 19.0%
Dividend growth (1Y) 2.1% – -0.9%
Dividend CAGR (3Y) 3.1% – -0.2%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAILMNTECH
Forward P/E 26.9xFY2026 54.2xFY2026 33.5xFY2027
EPS, next fiscal year $6.54FY2026 $5.00FY2026 $2.17FY2027
EPS growth, next FY +17.0%FY2026 +3.3%FY2026 +12.4%FY2027
EPS growth, the year after +0.6% +25.4% +4.6%
Revenue, next fiscal year $7.87BFY2026 $4.52BFY2026 $1.19BFY2027
Revenue growth, next FY +15.3%FY2026 +4.1%FY2026 -2.1%FY2027
Revenue growth, the year after -5.6% +12.0% +13.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAILMNTECH
Held by institutions 92.6% 100.0% 100.0%
Institutions holding 1,122 933 597
Change in shares held, QoQ +3.2% +0.0% -0.6%
Institutions buying 599 463 293
Institutions selling 350 330 241
Buyers to sellers 1.71 1.40 1.22

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AILMNTECH
A 1.00 0.48 0.48
ILMN 0.48 1.00 0.22
TECH 0.48 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, A, ILMN and TECH?

Agilent Technologies (A) is the largest by market capitalisation: Agilent Technologies (A) $49.61B, Illumina (ILMN) $40.93B, Bio-Techne (TECH) $11.35B.

Which stock is cheaper, A, ILMN and TECH?

Agilent Technologies (A) trades on the lowest price-to-earnings ratio (Agilent Technologies (A) 34.5x, Illumina (ILMN) 49.6x, Bio-Techne (TECH) 62.3x). On next year's consensus earnings, Agilent Technologies (A) is cheapest (Agilent Technologies (A) 26.9x, Illumina (ILMN) 54.2x, Bio-Techne (TECH) 33.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Agilent Technologies (A) grew revenue fastest over the trailing twelve months: Agilent Technologies (A) +8.6%, Illumina (ILMN) +4.9%, Bio-Techne (TECH) -0.4%.

Which company is more profitable?

Agilent Technologies (A) has the highest net margin (Agilent Technologies (A) 19.5%, Illumina (ILMN) 18.4%, Bio-Techne (TECH) 15.0%). On return on invested capital, Illumina (ILMN) leads (Agilent Technologies (A) 13.1%, Illumina (ILMN) 15.1%, Bio-Techne (TECH) 8.3%).

Which stock has performed better?

Over the past year Illumina (ILMN) returned the most: Agilent Technologies (A) +18.9%, Illumina (ILMN) +170.7%, Bio-Techne (TECH) +10.3%. Over five years, Agilent Technologies (A) compounded fastest (Agilent Technologies (A) +2.5%/yr, Illumina (ILMN) -7.5%/yr, Bio-Techne (TECH) -10.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Agilent Technologies (A) has the highest dividend yield: Agilent Technologies (A) 0.59%, Bio-Techne (TECH) 0.44%. Illumina (ILMN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Agilent Technologies (A) has been the steadiest (Agilent Technologies (A) 32.4%, Illumina (ILMN) 50.4%, Bio-Techne (TECH) 43.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, A, ILMN and TECH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Agilent Technologies (A) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.